Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
John J. Chen(Mayo Clinic in Arizona), Sean J. Pittock(Mayo Clinic), M. Tariq Bhatti, Jeffrey L. Bennett(University of Colorado Denver), Shannon Beres(Jisc), Divyanshu Dubey(Mayo Clinic in Arizona), A. Sebastian López‐Chiriboga, Eoin P. Flanagan(Mayo Clinic in Arizona), Eric Eggenberger(Michigan State University), Victoria S. Pelak(University of Colorado Denver), Brian G. Weinshenker(Mayo Clinic in Arizona), Jiraporn Jitprapaikulsan(Siriraj Hospital), Claudia F. Lucchinetti(Mayo Clinic in Arizona), Gregory Van Stavern(Jisc), Dean M. Cestari(Jisc), Andrew McKeon(Mayo Clinic), Aubrey L. Gilbert(Jisc), Vanda A. Lennon(Mayo Clinic), Collin M. McClelland(University of Minnesota), Marie D Acierno(Mayo Clinic in Arizona), Hadas Stiebel‐Kalish(Humboldt-Universität zu Berlin), Grayson W. Armstrong(Jisc), Ore-ofe O. Adesina, Michael S. Lee(Duke Medical Center), Heather E. Moss(University of Pennsylvania), Gena Heidary(Jisc), James P. Fryer(Mayo Clinic in Arizona), Veeral Shah(Jisc), Byron L. Lam(Jisc), Amy Kunchok(Cleveland Clinic), Jan‐Mendelt Tillema, Dean M. Wingerchuk(WinnMed)
Cited by 231
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k